Christine Savage is a Rheumatology/Immunology physician. OpenAlex indexes 75 publications with 1,000 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12977 Southern Blvd Ste 200
Loxahatchee, FL 334709256
Telephone
561-798-8184Provider last certified this registry record 7 May 2026.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year202542 payments$28,059openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202578 payments
- ABBVIE INC.Program year202529 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
62.4%TNF inhibitor56.3%Certolizumab pegol100%Enbrel Sureclick0%Part D + Part B<11 patientsSelective T Cell Costimulation Modulator5.5%Abatacept100%Part B, office-administered≥17 patients+ 9 more classes in this area
Musculoskeletal
35%Other drugs affecting bone structure and mineralization26.7%Romosozumab-aqqg100%Evenity (2 Syringes)0%Part D + Part B<11 patientsRANK Ligand Inhibitor8%Denosumab100%Part B, office-administered≥83 patients+ 6 more classes in this area
Nervous system
0.9%Gabapentinoids0.3%Gabapentin55%Pregabalin45%Part D≥40 patientsOpioid Agonist0.1%Tramadol Hcl100%Part D≥33 patients+ 11 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Changes in Nursing Students' Attitudes and Perceptions After Receipt of Enhanced Substance Use-Related Curricular Content
Journal of Addictions Nursing
2021 - Virtual currency in sanctioned jurisdictions: stepping outside of SWIFT
Journal of Investment Compliance
2019 - Hazardous Drinking Prevalence and Correlates in Older New Zealanders: A Comparison of the AUDIT-C and the CARET
Journal of Aging and Health
2018
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”